| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |